Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.33027 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.19745 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.20068 | 50 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.08844 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.11349 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.30377 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.28485 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.18719 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.15347 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.18248 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.1927 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.1286 | 49 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.23307 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.20119 | 50 |